Literature DB >> 8435921

Photoaging and the skin. The effects of tretinoin.

L J Green1, A McCormick, G D Weinstein.   

Abstract

The appearance of photoaged skin is cosmetically unacceptable to many in our society. Ostensibly, avoidance of ultraviolet light and sunlight from early childhood is most desirable but not likely to happen in our culture. Tretinoin is the only pharmacologic compound shown to partially reverse some signs of photoaging. Improvement with tretinoin therapy has been quantified clinically and histologically. A major degree of improvement occurs in 6 to 12 months, and maintenance treatment one to three times per week may continue this response. Tretinoin therapy should optimally be used with daily moisturizer and sunscreen applications. Psychosocial benefits of tretinoin therapy, use of tretinoin for intrinsically aged or non-Caucasian skin, and higher-strength tretinoin therapy for severely photoaged skin need to be further explored. It is possible that some subsets of patients with photoaged skin may respond better than others.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435921

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

Review 1.  The role of topical retinoids in the treatment of photoaging.

Authors:  Alexander J Stratigos; Andreas D Katsambas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Tretinoin. A review of its pharmacological properties and clinical efficacy in the topical treatment of photodamaged skin.

Authors:  S Noble; A J Wagstaff
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

3.  Application of ultrasound-mediated adapalene-coated lysozyme-shelled microbubbles in UVA-induced skin photoaging.

Authors:  Ai-Ho Liao; You-Lin Cai; Ho-Chaio Chuang; Cheng-Ying Lee; Yu-Chun Lin; Chien-Ping Chiang
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 4.  Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.

Authors:  Siddharth Mukherjee; Abhijit Date; Vandana Patravale; Hans Christian Korting; Alexander Roeder; Günther Weindl
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.